Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-06-07FDA Approved: PIOGLITAZONE — Supplemental Application (NorthStar RxLLC)
FDA approved a supplemental application for Pioglitazone submitted by NorthStar RxLLC.
-
FDA approval · 2023-06-07FDA Approved: PIOGLITAZONE AND METFORMIN HYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
The FDA approved a supplemental application for a Pioglitazone and Metformin Hydrochloride combination tablet from Macleods Pharmaceuticals …
-
FDA approval · 2023-06-07FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for METFORMIN HYDROCHLORIDE by Macleods Pharmaceuticals Limited (ANDA206955).
-
FDA approval · 2023-06-07FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
The FDA approved a supplemental application for Metformin hydrochloride from Macleods Pharmaceuticals Limited.
-
CLINICAL_TRIALS trial_result · 2023-06-06Clinical Trial Update: Effect of Dapagliflozin on Hepatic and Renal Glucose Metabolism Subjects [Phase 4]
A Phase 4 clinical trial assessed the effect of dapagliflozin on hepatic and renal glucose metabolism in adults with type 2 diabetes; result…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-06-05Clinical Trial Update: Effect of Saxagliptin and Dapagliflozin on Endothelial Progenitor Cell in Patients With Type 2 Diabetes Mellitus [Phase 4]
Phase 4 trial investigating the effects of saxagliptin and dapagliflozin on endothelial progenitor cells in patients with type 2 diabetes me…
-
CLINICAL_TRIALS trial_result · 2023-06-05Clinical Trial Update: Effects of Empagliflozin on Liver Fat Content, Energy Metabolism and Body Composition in Patients With Type 2 Diabetes [Phase 4]
Phase 4 trial investigating the effects of empagliflozin on liver fat content, energy metabolism, and body composition in patients with type…
-
CLINICAL_TRIALS trial_result · 2023-06-02Clinical Trial Update: Efficacy and Safety of LID104 in the Treatment of Type II Diabetes Mellitus [Phase 3]
Phase 3 trial assessing efficacy and safety of LID104 for type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2023-06-02Clinical Trial Update: Evaluation of Updated Continuous Glucose Monitoring (CGM) Form Factor in Adults, Adolescents and Pediatrics [NA]
Completed clinical trial evaluating an updated continuous glucose monitoring (CGM) form factor in adults, adolescents, and pediatrics with T…
-
CLINICAL_TRIALS trial_result · 2023-06-01Clinical Trial Update: Assess Efficacy and Safety of Epeleuton in Patients With Hypertriglyceridemia and Type 2 Diabetes [Phase 2]
Phase 2 clinical trial assessing efficacy and safety of epeleuton in patients with hypertriglyceridemia and Type 2 diabetes has been termina…
-
EMA approval · 2023-06-01EMA Authorised: Pioglitazone Actavis (pioglitazone hydrochloride) — Actavis Group PTC ehf
Authorisation granted for Pioglitazone Actavis (pioglitazone hydrochloride) for type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2023-05-31Clinical Trial Update: Clinical Trial of Pioglitazone Treatment in Patients With Type 2 Diabetes Mellitus and Covid-19 [Phase 4]
Phase 4 clinical trial evaluating pioglitazone in patients with type 2 diabetes mellitus and covid-19 has completed.
-
CLINICAL_TRIALS trial_result · 2023-05-31Clinical Trial Update: Detemir Energy Expenditure Study [Phase 4]
A Phase 4 clinical trial update for detemir assessing energy expenditure in individuals with type 2 diabetes mellitus and obesity has comple…
-
CLINICAL_TRIALS research · 2023-05-31Clinical Trial Update: Ox Bile- Conjugated Bile Acids Sodium in Type II Diabetes Mellitus [Phase 2]
Phase 2 trial evaluating ox bile-conjugated bile acids sodium in adults with type 2 diabetes mellitus and obesity; study completed with resu…
-
FDA approval · 2023-05-30FDA Approved: INSULIN GLARGINE — Supplemental Application (Biocon Biologics Inc.)
FDA approved Biocon Biologics Inc.'s supplemental Biologics License Application for insulin glargine-YFGN, a biosimilar insulin glargine pro…
-
FDA approval · 2023-05-26FDA Approved: INPEFA — Original Application (Lexicon Pharmaceuticals, Inc.)
FDA approved the original application for INPEFA (sotagliflozin) by Lexicon Pharmaceuticals.
-
FDA approval · 2023-05-26FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
The FDA approved a supplemental application for Metformin Hydrochloride from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc., …
-
CLINICAL_TRIALS trial_result · 2023-05-25Clinical Trial Update: Comparison of Oral Semaglutide w/ Placebo- Treatment for Latino Adults w/T2 Diabetes Receiving Enhanced Lifestyle Care [Phase 4]
A Phase 4 trial comparing oral semaglutide with placebo plus enhanced lifestyle care in Latino adults with type 2 diabetes; the study status…
-
CLINICAL_TRIALS trial_result · 2023-05-24Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Pioglitazone 15mg or 30mg Add-on in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin [Phase 3]
Phase 3 trial evaluating pioglitazone 15 mg or 30 mg as add-on therapy to metformin and dapagliflozin in inadequately controlled type 2 diab…
-
CLINICAL_TRIALS trial_result · 2023-05-24Clinical Trial Update: A Study of Dulaglutide (LY2189265) in Chinese Participants With Type 2 Diabetes [Phase 3]
A Phase 3 clinical trial update for dulaglutide in Chinese participants with type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2023-05-23Clinical Trial Update: Effect of Dihydromirycetin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Type 2 Diabetes Mellitus [Phase 2]
Phase 2 trial exploring the effect of dihydromyr icetin on glycemic control, insulin sensitivity, and insulin secretion in type 2 diabetes m…
-
CLINICAL_TRIALS trial_result · 2023-05-17Clinical Trial Update: Extended Release Exenatide Versus Placebo In Diabetic Patients With Type 4 Cardiorenal Syndrome [Phase 3]
A Phase 3 trial comparing extended-release exenatide with placebo in diabetic patients with Type 4 cardiorenal syndrome has completed enroll…
-
CLINICAL_TRIALS trial_result · 2023-05-17Clinical Trial Update: Incretin and Treatment With Inhibition of Sodium-glucose Cotransporter-2 Combination Insights Into Mechanisms Implicated in Congestive Heart Failure: "NATRIURETIC" Trial [Phase 2]
Phase 2 clinical trial exploring the combination of incretin therapy and SGLT2 inhibition in type 2 diabetes with potential insights into he…
-
CLINICAL_TRIALS trial_result · 2023-05-16Clinical Trial Update: Impact of LTBI Treatment on Glucose Tolerance and Chronic Inflammation [Phase 4]
Phase 4 clinical trial assessing how latent tuberculosis infection treatment affects glucose tolerance and chronic inflammation.
-
CLINICAL_TRIALS trial_result · 2023-05-16Clinical Trial Update: Evaluation of a Computer-Based, Self-Management Tool for People With Type 2 Diabetes [NA]
This is a completed clinical trial evaluating a computer-based self-management tool for people with type 2 diabetes; results have been poste…